Stephen Y.T. Chan
Impact in
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- PARP inhibition in cancer therapy
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 73
- Cancer Treatment and Pharmacology 28
- HER2/EGFR in Cancer Research 19
- PARP inhibition in cancer therapy 10
- Cancer-related Molecular Pathways 9
-
- Breast Cancer Treatment Studies 25
- Co-authors
- Tadeusz Pieńkowski (2 shared papers)Arlene Chan (3 shared papers)Mark S. Berger (2 shared papers)John P. Crown (2 shared papers)Mario Campone (5 shared papers)David Cameron (3 shared papers)Dimosthenis V. Skarlos (1 shared paper)Charles Edward Geyer Jr (1 shared paper)
- Journals
- British Journal of Cancer (19 papers)Breast Cancer Research and Treatment (12 papers)Journal of Clinical Oncology (11 papers)Annals of Oncology (11 papers)Clinical Oncology (7 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Stephen Y.T. Chan
175 papers receiving 13.3k citations
Stephen Y.T. Chan's Hit Papers
Peers
Comparison fields: 5 of 137
- Oncology 7.4k
- Cancer Research 2.8k
- Pulmonary and Respiratory Medicine 2.6k
- Molecular Biology 4.1k
- Radiology, Nuclear Medicine and Imaging 1.3k
Countries citing papers authored by Stephen Y.T. Chan
This map shows the geographic impact of Stephen Y.T. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Y.T. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Y.T. Chan more than expected).
Fields of papers citing papers by Stephen Y.T. Chan
This network shows the impact of papers produced by Stephen Y.T. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Y.T. Chan. The network helps show where Stephen Y.T. Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Y.T. Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 180 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer Hit paper breakdown → | 2006 | 2764 |
| 2 | RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer Hit paper breakdown → | 2011 | 858 |
| 3 | Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial Hit paper breakdown → | 2018 | 701 |
| 4 | A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses Hit paper breakdown → | 2008 | 642 |
| 5 | 1999 | 559 | |
| 6 | 2005 | 411 | |
| 7 | Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial Hit paper breakdown → | 2019 | 327 |
| 8 | 2003 | 315 | |
| 9 | 2008 | 291 | |
| 10 | 2004 | 261 | |
| 11 | 2013 | 222 | |
| 12 | 2020 | 197 | |
| 13 | 2015 | 191 | |
| 14 | 2008 | 182 | |
| 15 | 2003 | 161 | |
| 16 | 2004 | 142 | |
| 17 | 2004 | 137 | |
| 18 | 2014 | 132 | |
| 19 | 2010 | 129 | |
| 20 | 2004 | 128 |
About Stephen Y.T. Chan
Stephen Y.T. Chan is a scholar working on Oncology, Cancer Research, Molecular Biology, Reproductive Medicine and Genetics, having authored 180 papers that have together received 13.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (28 papers), DNA Repair Mechanisms (26 papers), Breast Cancer Treatment Studies (25 papers), HER2/EGFR in Cancer Research (19 papers), Ovarian cancer diagnosis and treatment (11 papers), Estrogen and related hormone effects (11 papers), PARP inhibition in cancer therapy (10 papers) and Cancer-related Molecular Pathways (9 papers). The work is most often cited by research in Oncology (7.4k citations), Cancer Research (2.8k citations), Pulmonary and Respiratory Medicine (2.6k citations), Molecular Biology (4.1k citations) and Radiology, Nuclear Medicine and Imaging (1.3k citations). Stephen Y.T. Chan has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Tadeusz Pieńkowski, Arlene Chan, Mark S. Berger, John P. Crown, Mario Campone, David Cameron, Dimosthenis V. Skarlos, Charles Edward Geyer Jr, Deborah L. Lindquist and Bella Kaufman. Their work appears in journals such as British Journal of Cancer, Breast Cancer Research and Treatment, Journal of Clinical Oncology, Annals of Oncology and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.